Book ChapterDOI
Plasma and tissue binding of psychotropic drugs
Marcel H. Bickel,U. E. Honegger +1 more
- pp 173-176
TLDR
The large number of binding studies carried out in recent years rather reflects the fact that there is a multitude of additional drug binding sites, such as metabolic and transport sites, as well as a variety of non-specific sites.Abstract:
Most pharmacological actions are the result of binding of drug molecules to specific receptors. However, only in a few instances are these receptors known entities which lend themselves to investigation. Thus, the large number of binding studies carried out in recent years rather reflects the fact that there is a multitude of additional drug binding sites, such as metabolic and transport sites, as well as a variety of non-specific sites. The latter are also called ‘silent receptors’ or ‘sites of loss’ since their occupation does not result in pharmacological actions. However, this kind of binding is believed to be a major determinant of pharmacokinetics which again modifies pharmacodynamics.read more
References
More filters
Journal ArticleDOI
Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components.
TL;DR: The binding of model drugs to human blood and individual blood components has been determined by equilibrium dialysis and expressed in terms of classes of binding sites, association constants and binding capacities.